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Summary 
Generic frameworks for the economic analysis of farm animal disease are now well 
established. The paper, therefore, uses bovine viral diarrhoea (BVD) as an example to 
explore how these frameworks need to be adapted to fit the characteristics of a particular 
disease and the specific objectives of the analysis. In the case of BVD the relative strength 
of tests available to correctly identify and then cull the virus positive animals has placed 
considerable emphasis on cost-benefit analysis of regional and national 
certification/eradication schemes. Such schemes in turn raise interesting questions about 
farmer uptake and maintenance of certification schemes, their equity and cost-effective 
implementation. The complex epidemiology of BVDV infections and the long-term, 
widespread and often occult nature of BVD effects make economic analysis of the disease 
and its control particularly challenging. However, this has resulted in a wider whole-farm 
perspective that captures the influence of decision making beyond those directly associated 
with disease prevention and control. There has been the need to include management of 
reproduction, risk and enterprise mix in the research on farmer decision making, which in 
turn impinge on and are affected by BVD. 
Keywords 
 
Introduction 
Generic frameworks suited to the economic assessment of endemic farm animal disease 
(e.g.[1], [2], [3]) are now well established and have been applied to a range of endemic 
diseases including BVD. For reviews see [4], [5], [6]. However, it is vital that these generic 
frameworks are suitably adapted to fit both the objective of the analysis and the specific 
characteristics of the disease in question. The case of BVD brings particular challenges in 
these regards, which have not previously been fully addressed. In many instances, tackling 
these challenges provides insights of potential value for economic analysis of diseases other 
than BVD. This paper is therefore focused on this point.  
Clear objectives for economic assessment of farm animal disease help to define the scope 
of the analysis and ensure that the appropriate methodologies are selected. A valuable 
table, adapted from [7], sets out a typology for the economics of animal disease (Table 1). It 
serves to illustrate the breadth of important research questions, range of sectors and the 
extent of inter-disciplinary collaboration encompassed in the general area of the economics 
of animal health, which are all relevant to BVD. However, to date the greatest emphasis for 
this disease has been at producer level and at the national/regional sectors in support of 
certification. These analyses have been carried out to persuade producers to adopt specific 
strategies or change their behaviours in other ways that have been shown to provide the 
greatest private and/or public benefit through the reduction of disease incidence and/or 
impact. There have also been a number of economic studies ([8] to [9]) to demonstrate that 
BVD has been, and remains, a cause of significant economic loss to cattle farmers across 
the world. 
Epidemiological features of importance for economic analysis 
The syndrome caused by BVD (bovine viral diarrhoea) virus (BVDV) is one of a group of 
economically important livestock pathogens known as Pestiviruses [10]). The virus 
engenders a wide range of pathogenic features [11], which often go unnoticed or are 
misattributed. This makes it particularly difficult both to capture the full extent of the 
economic impact, and even if they are available to use the results to persuade producers to 
change behaviour on BVD interventions for individual or societal benefits. One reason for 
misattribution is that BVDV causes immuno-suppression [12] giving rise to general effects 
such as increased enteritis and pneumonia amongst calves, infertility and abortion in cows 
[13].  
The transmission mechanisms of the virus also contribute to its occult nature and influences 
both output loss and effective control expenditure [14]. BVDV is transmitted in several ways 
but mainly from persistently infected (PI) animals to susceptible ones through direct contact. 
If the susceptible animal is a cow in the first trimester of pregnancy, then virus may be 
transmitted to the foetus. This may cause abortions resulting in reduced fertility. If the calf 
that was infected in the uterus is born it will be a PI, its immune system has no ability to limit 
BVDV multiplication. A PI may or may not show signs of ill thrift and may go on to produce a 
PI calf or calves of its own. Unless diagnosed by blood test and culled as part of a control 
programme its status may not become apparent. However, PI animals are susceptible to 
sudden death from mucosal disease [15]. Transiently infected cattle, which are infected by 
PIs, by contrast show only mild and temporary impairment in production followed by 
permanent immunity but frequent reproductive issues. The development of immunity within a 
herd, the increased propensity of PI animals to exit and regular entry of susceptible calves 
will cause the disease profile and hence output losses to fluctuate over time even within a 
closed herd. This dynamic component adds to the challenge for the economic analyst. 
Furthermore, there are two strains of BVDV. BVDV-1 is dominant in Europe while BVDV-2 is 
common (about 50% of isolates) in North America, associated with more acute symptoms 
[16] and hence is likely to have a different level of economic impact. 
Between herd spread is likely both through direct contact with PIs across farm boundaries 
and by purchase of PI replacement stock. It follows that good bio-exclusion practices are an 
important aspect of prevention that can also bring benefits from mitigating other disease 
risks [17]. Although vaccination is an option, it has no effect on PIs already present, on the 
birth of susceptible calves or the introduction of other susceptible animals likely to come into 
contact with any PIs. Farmers and vets often fail to appreciate the limitations of the various 
vaccines available and the importance of using them properly as part of a wider animal 
health programme [18]. It is therefore important that economic analysis is conducted and 
communicated to them in ways that best address these and the other problematic aspects of 
the disease. 
Herd prevalence is generally high in Europe. In countries where no national eradication 
programme exists, about 50% of herds may contain at least one PI [15]. These prevalences 
contribute to the high economic impact of BVD that is so widely reported.  
Dynamic aspects 
The above features of BVD aetiology and epidemiology have given rise to several 
mathematical simulation models that attempt to capture the key stochastic and dynamic 
processes involved and thus help to explore important relationships between risk factors and 
prevention/control interventions that are a prelude to economic analysis. Examples include 
[19], [20], [21], [22], [23]. Some have been used to examine the economic consequences of 
BVDV (e.g. [24], [25]).  
State-transition (modified Markov Chain) models provide a simple spreadsheet based 
platform for combining epidemiological and herd structure features important to the 
progression of infectious disease [26]. Stott et al. [27] describe how the stochastic functions 
in the spreadsheet may be used to draw samples of herds of alternative epidemiological 
status to seed multiple runs representative of current observed prevalence. The state 
transition model (STM) may then be used to explore the progression of the disease and 
hence associated financial loss under alternative control strategies and farm circumstances. 
Counterfactual prevalence assumptions can then expose the progressive impacts of 
alternative national/regional policy interventions such as eradication programmes. These are 
likely to exhibit quite different impacts on individual farm businesses at the start (pioneers 
with susceptible herds exposed to risk from PIs in the wider population) and end 
(persistence of laggards holding PIs) than in the middle of the programme [28]. Where a 
long-run steady state exists in a STM, this may provide a convenient platform from which to 
summarise financial outcomes and benchmark alternative scenarios [29]. However, this 
creates a temptation to neglect the cashflow and associated risk implications characteristic 
of dynamic BVDV epidemics [27] which is an important and arguably under researched 
aspect of the economics of BVD and its control.  
In terms of economic impact, the key dynamic aspect of BVDV epidemics in breeding herds 
is reproductive impairment and failure. Varo Barbudo [30] modelled these reproductive 
aspects explicitly based on a survey of reproductive performance and management in 106 
commercial Scottish beef suckler (cow-calf) herds. This work confirmed that hidden losses 
due to impacts of BVDV on reproduction although extremely variable are likely to be 
considerable, perhaps doubling previous estimates of the total costs of BVD in such herds. 
Moreover, disease impacts were masked by use of long breeding seasons, suggesting that 
continued presence of BVDV in Scotland could frustrate programmes of sustainable 
intensification [31] aimed at improving the efficiency of food production while lowering its 
carbon footprint. In dairy herds Heuer et al. [32] provide a recent demonstration of the 
economic impacts of BVDV in New Zealand dairy herds, their similarity to results from 
elsewhere in the world and the strong relationships between some indicators of poor 
reproductive performance and high BVDV antibody titres in the bulk milk tank. Given the 
importance of reproductive management for sustainability in the dairy herd [33] it would be 
useful to more explicitly explore the relationships between management of reproduction and 
BVDV prevention/control in future research. 
Economic analysis 
A central contribution of the generic economic frameworks for assessment of endemic 
animal disease is to shift emphasis from estimates of average total costs (output losses plus 
control expenditure) to establishment of avoidable losses i.e. the difference between current 
total cost and minimum total cost [34]. Such analyses demand understanding of the 
production function relationships linking increasing disease control expenditures with 
reducing output losses [4] and are therefore more demanding of epidemiological data and 
models. However, they establish the opportunity cost of current practice and identify the 
means by which such costs might be saved. These are of course key issues for decision 
support at both farm and regional/national level. 
As BVD includes such a complex and occult disease syndrome, few empirical economic 
analyses of it based on the loss-expenditure frontier (LEF) method of [1] have been 
attempted with an exception being Chi et al [17]. The latter used the framework to make a 
comparative assessment on a common basis of four production-limiting diseases (enzootic 
bovine leucosis, Johne’s Disease and neosporosis as well as BVD) in Canadian dairy farms. 
Although the relatively small (90-herd) cross-sectional study had limitations it did 
demonstrate how important it can be to aggregate the benefits of generic prevention 
measures (e.g. sometimes collectively represented within umbrella biosecurity) across the 
range of disease losses avoided. 
 
Although a LEF applied to a large sample of herds can establish the aggregate extent of 
avoidable loss and hence aid resource allocation at regional/national level it may fail to 
identify the most appropriate prevention and control strategies under specific circumstances 
at individual farm level. Stott and Gunn [35] therefore adapted the generic benefit function 
framework of Tisdell [2] to alternative farm-level prevention/control decisions against 
simulated BVD epidemics in suckler herds.  The approach is summarised in Figure 1. This 
shows relationships between cumulative investments in ‘biosecurity’ (i.e. a range of additive 
options see [35] for details) and the output losses saved as a consequence (benefit). 
Maximum net benefits vary widely from under £2/cow/year from a £5/cow/year investment 
for an unvaccinated herd of unknown health status (function 1) through to over £26/cow/year 
from a £6/cow/year investment for a vaccinated herd known to be free of BVDV at the start 
of the simulation (function 4). Note that extra investment in biosecurity (beyond a basic 
minimum not included in the benefit function) is justified even when vaccine is used. 
Knowledge that a herd is free of the virus justifies much greater investment in disease 
prevention to help ensure that it stays that way. It can be seen from Figure 1 that more 
biosecurity not less is justified when vaccine is used in a herd where BVDV status is 
unknown (function 2-1). The reverse is true for herds tested free of the virus (function 3-4). 
This highlights the importance of the interaction between vaccination and certification and 
hence the potential for synergy between individual farm and regional (health scheme) BVDV 
response strategies. All these observations demonstrate the practical insights that bio-
economic analysis can bring. Outcomes are of course dependent upon the assumptions 
made, some of which are hard to verify in specific practice. However, the rules of thumb (if 
not the specific financial outcomes) provide the basis for interaction with stakeholders and 
hence the iterative development of the models and associated decision support.  
 
Uptake by farmers  
It is clear from the previous example that economics is not about money but concerned with 
understanding rational choices about the allocation of scarce resources between competing 
activities in ways that best meet decision makers’ goals [36]. This begs the question as to 
whether economic analysis of BVD is influencing farmers’ decision making and so achieving 
the net benefits it promises. A key problem here was highlighted by Gates [37] who reported 
that only 27% of beef farmers and 25% of dairy farmers with seropositive herds identified in 
a prevalence survey thought that their cattle were affected by BVDV. However, as 
biosecurity is central to BVDV prevention [38] and farmers are aware of its generic 
importance, behaviour change yielding public and private benefits through reduced 
prevalence of BVDV may be obtained through a focus on uptake by farmers of good 
biosecurity practice. 
Toma et al. [39] explained 64% of the variance in biosecurity behaviour of 900 British cattle 
and sheep farmers using behavioural economics methods. They demonstrated the relative 
importance and inter-relationships between drivers of biosecurity actions such as knowledge 
of specific measures and perceptions of their importance. These insights could guide policy 
makers towards most effective behavioural change campaigns amongst farmers especially if 
linked to economic analysis of BVD to estimate the benefits of such campaigns.  
Veterinary practitioners perceive their clients to be reluctant to invest in biosecurity and feel 
that additional proof of efficacy and/or economic benefit is required [40]. However, Heffernan 
et al. [41] uncovered a potentially important alternative view that calls into question sole 
reliance on economic analysis as a driver of uptake of biosecurity and presumably other 
animal disease prevention strategies. In their interviews of 121 cattle and sheep farmers in 
South-West England and Wales, most were dismissive of the many measures associated 
with biosecurity. Farmers justified their views in terms of blame, citing external people 
responsible for inadequate border control and ineffective policy and regulation of epidemic 
disease. In the case of endemic diseases like BVD, ‘bad’ farmers were seen as the problem. 
This result demonstrates how important it is to use a wide definition of economics in animal 
health that encompasses behavioural change and not relying exclusively on the quantitative 
estimates of the costs and benefits of a disease and its control – the classic cost-benefit 
studies.  
Risk 
In many exchanges with farmers and veterinary practitioners, the authors have encountered 
another problem with farmers’ perceptions of economic analysis of BVD and other endemic 
diseases. Published and promoted average total costs of endemic diseases and even 
avoidable losses derived from them appear implausibly high. In the case of BVD this could 
be attributed to its multi-faceted and occult nature. However, the distributions of disease 
costs are often positively skewed i.e. published means are higher than their medians [42]. 
For example, the mean total health-control costs in Euros per cow per year in a survey of 
248 French dairy farms was 86, the median 81 and the maximum 252 [43]. This observation 
exposes another often neglected aspect of the economics of animal health that outbreaks of 
disease represent an important aspect of production risk and this may be a more important 
motivator for the farmer than the average avoidable losses or the associated opportunity 
costs of sub-optimal prevention and control. Figure 2 shows the distribution of enteritis costs 
in suckled calves, which is often associated with a BVDV infection. The mean cost of an 
episode in this study [44] was approximately £30/calf at risk. However, 64% of the farmers 
concerned experienced episodes leading to costs that were less than this. They might 
reasonably be expected to consider the mean cost to be exaggerated. However, the most 
costly episodes were three to four times greater than the mean, exposing the businesses 
concerned to substantial financial loss. About 5% of episodes were in this high cost category 
i.e. there was a small but significant risk of important consequences for the whole farm from 
a condition that might otherwise be considered routine.  
The BVD example clearly shows how important it is that economics of animal health 
exposes risks to farm businesses in ways that properly support farmers’ decision making. 
Rushton [45] reviews the risks in the context of the economics of animal health and the tools 
available to incorporate it into associated economic analysis. The issue has particular 
importance for BVD outbreaks as not only does it contribute as other endemic diseases via 
production losses to variation in farm profits (a measure of risk) but if the herd is naïve 
perhaps following removal of PIs by testing and culling then ironically the potential for 
greater variation in loss (risk) may be increased (see Figure 3). In this example up to 10% of 
risk (variance in farm income) was due to BVDV in a naïve herd. In a herd of unknown BVDV 
status the ‘risk’ was no more than 4% and independent of farm income. The dependence of 
BVD risk on target farm income in a naïve herd reflects the greater income generated on 
such farms provided that greater investment is made in biosecurity to maintain disease 
freedom. This demonstrates the wider benefits of private health schemes or national 
eradication programmes that furnish such information and hence provide the motivation for 
greater investment in biosecurity. This investment is likely to generate additional benefits not 
included in the model. For example both public and private benefits from greater protection 
against diseases other than BVD are likely. The BVD-free herd also requires smaller 
enterprises operating at lower intensity than those in the otherwise equivalent herd of 
unknown BVDV status in order to achieve the same target farm income. This reduces risk 
from these activities and lowers their carbon footprint.  
National control programmes 
The wider benefits of freedom from BVDV at farm level illustrated by the last example help to 
justify investment in BVDV eradication programmes (Stott and Gunn, 2008 [35]). The 
benefits of reliable tests for BVD are however offset by the difficulties of ensuring universal 
uptake by farmers in voluntary schemes [28]. There has therefore been increased emphasis 
in Europe in recent years on compulsory national control schemes [15]. For example, Presi 
et al. [46] reports the testing of all Swiss cattle for BVD virus and the culling of all PIs. 
Prevalence of virus-positive newborn calves fell from 1.8% to under 0.2% in two years. 
Economic analysis provides an important role in demonstrating the ex-ante benefits thus 
helping policy makers to justify public investment in national BVDV eradication programmes. 
For example Valle et al. [47] showed positive net benefits for eradication in Norway, while 
Stott et al. [29] provided support for the Irish eradication programme. As these programmes 
progress they will provide data for a wide range of interdisciplinary work on the epidemiology 
and economics of BVDV prevention and control. This could help to improve the cost 
effectiveness of future schemes through for example more detailed work on alternative 
resource allocations in response to test results during a campaign rather than simple cost-
benefit of eradication vs the status quo. Such interactive approaches will be greatly 
strengthened by developments in phylogenetic analysis, which provides information about 
the diversity of virus strains involved in an epidemic, thus helping to trace the routes of viral 
transmission [48].   
 
Welfare aspects 
It is important in the case of BVD, as with many animal diseases to include not only the 
costs/benefits to farmers in economic analysis but also the benefits to other stakeholders. 
Weldegebriel et al. [49] used an economic welfare methodology to examine the distributional 
effects on actors in the milk market of a successful hypothetical programme to eradicate 
bovine viral diarrhoea virus from the Scottish dairy herd. As expected, milk supply to the 
market increased as a consequence of eradication leading to a fall in milk price. This 
benefited milk consumers (£11m in discounted economic surplus) but was a small detriment 
to producers already with disease-free herds (£2m). However, the lower milk price was more 
than offset by the greater volume of milk available for sale from previously infected herds 
(£39m gain), leading to an overall gain of £47m for Scotland. The example highlighted the 
important effects that national eradication programmes can have on commodity markets, 
leading in this instance to considerable net gains tempered by small losses in one sector. 
Considerations of equity and how these might be incorporated into incentive schemes 
associated with national disease control programmes deserve further economic research. 
Conclusion 
BVD provides a useful case study of the use of economics in animal health. Economic 
analysis has played an important role in the instigation of regional and national BVDV 
eradication programmes and demonstrated the considerable direct and wider benefits both 
public and private that such programmes can provide. It has highlighted the importance of 
generic biosecurity activities at farm level and exposed some of the important behavioural 
issues concerned. The generic and widespread effects of BVDV impacts at farm level have 
highlighted the importance of incorporating animal disease decision support into wider farm 
management systems. There is much scope for further development in this area not just to 
ensure maximum benefit from BVDV prevention for the farm business but also to provide a 
basis for development of sustainable intensification that meets growing global demand for 
more food production, of great quality, at less risk and with reduced impact on the 
environment.  
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 Figure 1: Benefit functions for investment in biosecurity against BVDV incursion for a typical 
50-cow suckler herd under standard epidemiological and economic conditions derived from 
Stott and Gunn [35]. Functions 1 and 2 represent BVDV status unknown at the start of the 
10-year simulated epidemic, while functions 3 and 4 are for herds tested free of BVDV at the 
outset. Functions 2 and 4 assume vaccination is used while 1 and 3 do not. The hatch line 
sloping at 45o is the cost function (break-even). Vertical hatch lines show the point of 
maximum net benefit (slope of benefit function equal to 1, i.e. marginal cost = marginal 
benefit = £1).  
 Figure 2: Unpublished results based on the study of Stott and Gunn [48] showing the 
distribution of enteritis costs in a sample of 105 separate episodes in suckler herds recorded 
in detail by four veterinary practices working in Northern Scotland.  
 Figure 3: Predicted effect of BVDV status on risk (proportion of income variance due to BVD) 
in a typical Scottish mixed farm including a 50-cow suckler herd, young stock, sheep flock 
and barley enterprise. Risk was minimised by a MOTAD LP model that could alter enterprise 
mix and other details of farm management including BVDV prevention provided a set farm 
income target was achieved. As income target rose higher risk strategies had to be adopted 
decreasing the relative importance of risk due to BVDV. The solid markers denote a farm 
free of BVDV at the start of a 10-year simulation. Open markers show an otherwise identical 
herd of unknown BVDV status. Further details are in [27]. 
